<div id="hybrid-search-3" class="widget search widget-search"><div class="widget-inside"><form method="get" class="search-form" id="search-form" action="https://rare-diseases.ca/"><div><input class="search-text" type="text" name="s" id="search-text" value="" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" /><input class="search-submit button" name="submit" type="submit" id="search-submit" value="Search" /></div></form><!-- .search-form --></div></div>
<div id="hybrid-nav-menu-3" class="widget nav-menu widget-nav-menu"><div class="widget-inside">
Home
Our Team
Investigators
Knowledge Users
Trainees
Former Trainees
Emerging Research Cluster
Research Units
The Centre for Clinical Epidemiology & Evaluation (C2E2)
The Centre for Health Evaluation and Outcome Sciences (CHÉOS)
Centre of Genomics and Policy (CGP)
Child & Family Research Institute (CFRI) – Genetics & Health Research
Collaboration for Outcomes Research and Evaluation (CORE)
Joint Centre for Bioethics (JCB)
The Ontario Drug Policy Research Network (ODPRN)
The Ottawa Hospital Research Institute (OHRI)
Toronto Health Economics and Technology Assessment (THETA) Collaborative
Current Projects
Implementation of Diagnostic Whole Genome Sequencing for Rare Diseases in British Columbia
GenCOUNSEL: Optimization of genetic counselling for clinical implementation of genome-wide sequencing
MILLION DOLLAR MED$
Clinical Assessment of the Utility of Sequencing and Evaluation as a Service (CAUSES)
Engaging publics on reimbursement decision-making for expensive drugs for rare diseases
Crowdfunding As a New Approach to Financing Orphan Drug R&D (CANAFORD)
Informing Future Orphan Drug Coverage Using Scenario Studies (iFOCUSS)
An Evaluation of Canadian Societal Values and Views on Funding and coverage of Expensive Prescription Medications
Narrative Bioethics and Popular Conceptions of Genetic Disorder
Resource Allocation for the Treatment of Rare Diseases
News
News & Media
Awards & Honors
Publications
Career Opportunities
Contact Us
</div></div>
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://rare-diseases.ca" title="" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://rare-diseases.ca/topics/slideshow/" rel="tag">Slideshow</a> <span class="sep">»</span> The Team’s Overarching Objectives Are To: </div></div>
The Team’s Overarching Objectives Are To:
Create a priority-setting and decision making framework for expensive drugs for rare diseases.